Jin Medical International Ltd
ZJYL0.209USD
+0.001+0.29%
收盤 12/19, 16:00（美東）報價延遲15分鐘
32.69M總市值
18.24本益比TTM
關於 Jin Medical International Ltd 公司
Jin Medical International Ltd is a holding company mainly engaged in the design and manufacturing of wheelchairs. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company mainly distributes its products in domestic and overseas markets.
Jin Medical International Ltd簡介
公司代碼ZJYL
公司名稱Jin Medical International Ltd
上市日期Mar 28, 2023
CEOWang (Erqi)
員工數量269
證券類型Ordinary Share
年結日Mar 28
公司地址No. 33 Lingxiang Road, Wujin District
城市CHANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編213149
電話8651989607972
網址
公司代碼ZJYL
上市日期Mar 28, 2023
CEOWang (Erqi)
Jin Medical International Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Ziqiang Wang
Mr. Ziqiang Wang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Oliver St. Clair Franklin
Mr. Oliver St. Clair Franklin
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Jourdan Frain
Mr. Jourdan Frain
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Yanru Guo
Ms. Yanru Guo
Independent Director
Independent Director
--
--
Mr. Erqi Wang
Mr. Erqi Wang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Ziqiang Wang
Mr. Ziqiang Wang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Oliver St. Clair Franklin
Mr. Oliver St. Clair Franklin
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Jourdan Frain
Mr. Jourdan Frain
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Yanru Guo
Ms. Yanru Guo
Independent Director
Independent Director
--
--
Mr. Erqi Wang
Mr. Erqi Wang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Wheelchair
14.87M
63.26%
Wheelchair components and others
8.64M
36.74%
地區USD
名稱
營收
佔比
Overseas market
14.89M
63.36%
China
8.61M
36.64%
業務
地區
業務USD
名稱
營收
佔比
Wheelchair
14.87M
63.26%
Wheelchair components and others
8.64M
36.74%
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Jolly Harmony Enterprises Ltd
60.93%
Er Pu International Ltd
7.50%
Gorgeous Abundant Enterprises Ltd
7.41%
Geode Capital Management, L.L.C.
0.07%
UBS Financial Services, Inc.
0.03%
其他
24.07%
持股股東
持股股東
佔比
Jolly Harmony Enterprises Ltd
60.93%
Er Pu International Ltd
7.50%
Gorgeous Abundant Enterprises Ltd
7.41%
Geode Capital Management, L.L.C.
0.07%
UBS Financial Services, Inc.
0.03%
其他
24.07%
股東類型
持股股東
佔比
Corporation
75.84%
Investment Advisor/Hedge Fund
0.07%
Investment Advisor
0.05%
Hedge Fund
0.01%
Venture Capital
0.01%
其他
24.02%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
30
699.59K
0.45%
-2.00M
2025Q2
33
119.73M
76.48%
-1.91M
2025Q1
33
119.73M
76.48%
-1.91M
2024Q4
32
120.65M
77.07%
-1.01M
2024Q3
32
120.51M
76.98%
-557.84K
2024Q2
30
119.95M
76.62%
-289.15K
2024Q1
26
119.50M
76.41%
+579.31K
2023Q4
14
129.79M
83.73%
+128.79M
2023Q3
12
130.08M
83.92%
+129.42M
2023Q2
6
130.21M
84.00%
+129.73M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Jolly Harmony Enterprises Ltd
95.38M
60.93%
--
--
Jan 14, 2025
Er Pu International Ltd
11.74M
7.5%
--
--
Jan 14, 2025
Gorgeous Abundant Enterprises Ltd
11.60M
7.41%
--
--
Jan 14, 2025
Geode Capital Management, L.L.C.
106.54K
0.07%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
93.83K
0.06%
-76.71K
-44.98%
Jun 30, 2025
Osaic Holdings, Inc.
22.40K
0.01%
+2.95K
+15.17%
Jun 30, 2025
Millennium Management LLC
68.24K
0.04%
-68.33K
-50.03%
Jun 30, 2025
HRT Financial LP
11.98K
0.01%
+11.98K
--
Jun 30, 2025
Tower Research Capital LLC
12.33K
0.01%
+4.69K
+61.43%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
Invesco Golden Dragon China ETF
0%
Vanguard Total World Stock Index Fund
佔比0%
Vanguard ESG International Stock ETF
佔比0%
Invesco Golden Dragon China ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Feb 07, 2024
Split
1→20
公告日期
類型
比率
Feb 07, 2024
Split
1→20
常見問題
Jin Medical International Ltd的前五大股東是誰？
Jin Medical International Ltd的前五大股東如下：
Jolly Harmony Enterprises Ltd持有股份：95.38M佔總股份比例：60.93%。
Er Pu International Ltd持有股份：11.74M佔總股份比例：7.50%。
Gorgeous Abundant Enterprises Ltd持有股份：11.60M佔總股份比例：7.41%。
Geode Capital Management, L.L.C.持有股份：106.54K佔總股份比例：0.07%。
UBS Financial Services, Inc.持有股份：93.83K佔總股份比例：0.06%。
Jolly Harmony Enterprises Ltd持有股份：95.38M佔總股份比例：60.93%。
Er Pu International Ltd持有股份：11.74M佔總股份比例：7.50%。
Gorgeous Abundant Enterprises Ltd持有股份：11.60M佔總股份比例：7.41%。
Geode Capital Management, L.L.C.持有股份：106.54K佔總股份比例：0.07%。
UBS Financial Services, Inc.持有股份：93.83K佔總股份比例：0.06%。
Jin Medical International Ltd的前三大股東類型是什麼？
Jin Medical International Ltd 的前三大股東類型分別是：
Jolly Harmony Enterprises Ltd
Er Pu International Ltd
Gorgeous Abundant Enterprises Ltd
Jolly Harmony Enterprises Ltd
Er Pu International Ltd
Gorgeous Abundant Enterprises Ltd
有多少機構持有Jin Medical International Ltd(ZJYL)的股份？
截至2025Q3，共有30家機構持有Jin Medical International Ltd的股份，合計持有的股份價值約為699.59K，占公司總股份的0.45% 。與2025Q2相比，機構持股有所增加，增幅為-76.03%。
哪個業務部門對Jin Medical International Ltd的收入貢獻最大？
在FY2024，Wheelchair業務部門對Jin Medical International Ltd的收入貢獻最大，創收14.87M，占總收入的63.26% 。
